Bioequivalence study of generic gliclazide and Diamicron formulations in healthy Thai male volunteersROJANASTHIEN, N; SUGUNTA, C; RUNGAPINAN, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 323-330, issn 0946-1965, 8 p.Article

Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumLOUBANI, Mahmoud; FOWLER, Alan; STANDEN, Nicholas B et al.European journal of pharmacology. 2005, Vol 515, Num 1-3, pp 142-149, issn 0014-2999, 8 p.Article

Study of the solubilization of gliclazide by aqueous micellar solutionsALKHAMIS, Khouloud A; ALLABOUN, Hussien; AL-MOMANI, Wafa'A Y et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 4, pp 839-846, issn 0022-3549, 8 p.Article

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulationsBERECKA, Anna; GUMIENICZEK, Anna; HOPKALA, Hanna et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 319-325, issn 1060-3271, 7 p.Article

Gliclazide inhibits differentiation-associated biologic events in human monocyte-derived macrophagesMAMPUTU, Jean-Claude; LING LI; RENIER, Geneviève et al.Metabolism, clinical and experimental. 2006, Vol 55, Num 6, pp 778-785, issn 0026-0495, 8 p.Article

Functional involvement of sulphonylurea receptor (SUR) type 1 and 2B in the activity of pig urethral ATP-sensitive K⁺ channelsYUNOKI, Takakazu; TERAMOTO, Noriyoshi; ITO, Yushi et al.British journal of pharmacology. 2003, Vol 139, Num 3, pp 652-660, issn 0007-1188, 9 p.Article

In Vitro and In Vivo Evaluation of a Novel Push-Pull Osmotic Pump with Orifices on Both Side SurfacesWEI LI; GANI DU; XINGGANG YANG et al.Drug development and industrial pharmacy. 2008, Vol 34, Num 12, pp 1350-1355, issn 0363-9045, 6 p.Article

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesCHARBONNEL, B; SCHERNTHANER, G; BRUNETTI, P et al.Diabetologia (Berlin). 2005, Vol 48, Num 6, pp 1093-1104, issn 0012-186X, 12 p.Article

Determination of aminoheterocycle and azabicycle in gliclazide bulk by capillary zone electrophoresis with amperometric detectionJIN LV; QINGJIANG WANG; XIANG CHEN et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 3-4, pp 843-847, issn 0731-7085, 5 p.Article

High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasmaKUO, Chien-Yuan; WU, Shou-Mei.Journal of chromatography. 2005, Vol 1088, Num 1-2, pp 131-135, issn 0021-9673, 5 p.Conference Paper

Population PKPD modelling of the long-term hypoglycaemic effect of gliclazide given as a once-a-day modified release (MR) formulationFREY, N; LAVEILLE, C; PARAIRE, M et al.British journal of clinical pharmacology. 2003, Vol 55, Num 2, pp 147-157, issn 0306-5251, 11 p.Article

Free radical scavenging activity of sulfonylureas: A clinical assessment of the effect of gliclazideJENNINGS, P. E; BELCH, J. J. F.Metabolism, clinical and experimental. 2000, Vol 49, Num 2, pp 23-26, issn 0026-0495, SUP1Conference Paper

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatmentSWEN, Jesse J; GUCHELAAR, Henk-Jan; BAAK-PABLO, Renee F et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 8, pp 461-468, issn 1744-6872, 8 p.Article

Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical settingGÖKALP, Osman; GUNES, Arzu; CAM, Hakan et al.European journal of clinical pharmacology. 2011, Vol 67, Num 12, pp 1223-1229, issn 0031-6970, 7 p.Article

Effect of gliclazide immobilization into layered double hydroxide on drug releaseAMBROGI, V; PERIOLI, L; CIARNELLI, V et al.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 73, Num 2, pp 285-291, issn 0939-6411, 7 p.Article

Mass spectra of gliclazide drug at various ion sources temperature: Its thermal behavior and molecular orbital calculationsZAYED, M. A; NOUR EL-DIEN, F. A; HAWASH, M. F et al.Journal of thermal analysis and calorimetry. 2010, Vol 102, Num 1, pp 305-312, issn 1388-6150, 8 p.Article

Comparison of the solubility and dissolution rate between gliclazide solid complex and its nanospheresLO, Yung-Kuang; CHEN, Chiu-Ju; TSAI, Tong-Rong et al.Drug development and industrial pharmacy. 2007, Vol 33, Num 3, pp 301-309, issn 0363-9045, 9 p.Article

Application of monolithic column in quantification of gliclazide in human plasma by liquid chromatographyFOROUTAN, S. M; ZARGHI, A; SHAFAATI, A et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 42, Num 4, pp 513-516, issn 0731-7085, 4 p.Article

Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol dietONOZATO, Maristela Lika; TOJO, Akihiro; GOTO, Atsuo et al.Kidney international. 2004, Vol 65, Num 3, pp 951-960, issn 0085-2538, 10 p.Article

Preparation and in vitro/in vivo evaluation of gliclazide loaded eudragit nanoparticles as a sustained release carriersDEVARAJAN, Padma V; SONAVANE, Ganeshchandra S.Drug development and industrial pharmacy. 2007, Vol 33, Num 2, pp 101-111, issn 0363-9045, 11 p.Article

Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with type 2 diabetesPERRIELLO, G; PAMPANELLI, S; DI PIETRO, C et al.Diabetic medicine. 2006, Vol 23, Num 3, pp 246-252, issn 0742-3071, 7 p.Article

Gliclazide at a lower concentration than therapeutic dose increases the sensitivity of insulin secretion to glucose in perfused rat pancreasMOKUDA, O; TANAKA, H; HAYASHI, T et al.Diabetes & metabolism. 2004, Vol 30, Num 2, pp 193-196, issn 1262-3636, 4 p.Article

Le médicament du mois : Gliclazide à libération modifiée (Uni Diamicron®) = Gliclazide modified release (Uni Diamicron®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 2003, Vol 58, Num 10, pp 641-645, issn 0370-629X, 5 p.Article

Mécanismes moléculaires de l'insulinosécrétion = Molecular mechanisms of insulin secretionBATAILLE, D.Diabetes & metabolism. 2002, Vol 28, pp 4S7-4S13, issn 1262-3636, SUPConference Paper